Form 4/A for CVS CVS Health
Accepted 2025-05-09 00:00:00 ET · period of report 2025-04-01 · accession 0001127602-25-013864 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-05-09 | 2025-04-01 | CVS | Joyner J. David | Pres, CEO, Dir | A - Grant | $0.00 | +53.3K | 82.5K | +183% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (RSUs) | 2025-04-01 | A | A | 53,324 | $0.00 | 82,515 | D | — | — | (F1) The purpose of this amendment is to correct the number and type of derivative securities granted to the reporting person on April 1, 2025, which was originally reported on a Form 4 filed on April 3, 2025 (the "Initial Form 4"). The Initial Form 4 incorrectly reported that the reporting person was granted stock options. As reported in this amendment, the reporting person was granted 53,324 restricted stock units ("RSUs"), awarded pursuant to Issuer's 2017 Incentive Compensation Plan, and not 226,138 stock options, as reported in the Initial Form 4. Restrictions on the RSUs lapse in four equal annual installments, commencing 4/1/2026. |